We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Innospec
IOSP
$2.09B
| $200K | ﹤0.01% |
3,240
-342
| -10% | -$23.5K |
|
|
NSA
1377
DELISTED
National Storage Affiliates Trust
NSA
| $200K | ﹤0.01% |
7,556
-800
| -10% | -$21.4K |
|
1378
Aurinia Pharmaceuticals
AUPH
$1.97B
| $197K | ﹤0.01% |
28,923
-5,415
| -16% | -$31.2K |
|
1379
Taylor Morrison
TMHC
$6.67B
| $197K | ﹤0.01% |
12,400
-1,410
| -10% | -$23K |
|
1380
Hope Bancorp
HOPE
$1.72B
| $196K | ﹤0.01% |
16,547
-1,809
| -10% | -$25.9K |
|
1381
O-I Glass
OI
$1.39B
| $196K | ﹤0.01% |
11,389
-2,799
| -20% | -$48.9K |
|
|
AKRX
1382
DELISTED
Akorn Inc
AKRX
| $196K | ﹤0.01% |
57,787
+35,272
| +157% | +$210K |
|
|
NSTG
1383
DELISTED
NanoString Technologies, Inc.
NSTG
| $194K | ﹤0.01% |
13,099
-2,124
| -14% | -$33.7K |
|
1384
Pitney Bowes
PBI
$2.42B
| $192K | ﹤0.01% |
32,454
-6,348
| -16% | -$45.7K |
|
|
CALY
1385
Callaway Golf Company
CALY
$3.26B
| $190K | ﹤0.01% |
12,397
-1,345
| -10% | -$26.9K |
|
|
ODP
1386
DELISTED
ODP
ODP
| $190K | ﹤0.01% |
7,372
-929
| -11% | -$26.6K |
|
|
WDR
1387
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $190K | ﹤0.01% |
10,482
-1,143
| -10% | -$22.3K |
|
|
PDLI
1388
DELISTED
PDL BioPharma, Inc.
PDLI
| $187K | ﹤0.01% |
64,580
-12,252
| -16% | -$33.7K |
|
|
FLXN
1389
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $185K | ﹤0.01% |
16,370
-3,160
| -16% | -$49.5K |
|
1390
AC Immune
ACIU
$227M
| $184K | ﹤0.01% |
+19,442
| New | +$184K |
|
1391
Prothena Corp
PRTA
$458M
| $183K | ﹤0.01% |
17,746
-3,418
| -16% | -$40.6K |
|
1392
Liberty Latin America Class C
LILAK
$1.5B
| $182K | ﹤0.01% |
14,611
-2,433
| -14% | -$37.5K |
|
|
EIDX
1393
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $182K | ﹤0.01% |
+13,218
| New | +$167K |
|
|
FTSV
1394
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $179K | ﹤0.01% |
+11,392
| New | +$174K |
|
1395
News Corp Class B
NWS
$16.4B
| $178K | ﹤0.01% |
15,402
-124,711
| -89% | -$1.63M |
|
1396
Corcept Therapeutics
CORT
$10.2B
| $177K | ﹤0.01% |
13,243
-1,375
| -9% | -$18.2K |
|
1397
BGC Group
BGC
$5.58B
| $174K | ﹤0.01% |
33,738
-20,519
| -38% | -$135K |
|
|
CVA
1398
DELISTED
Covanta Holding Corporation
CVA
| $174K | ﹤0.01% |
12,990
-2,121
| -14% | -$32.7K |
|
|
QEP
1399
DELISTED
QEP RESOURCES, INC.
QEP
| $173K | ﹤0.01% |
30,719
-835
| -3% | -$7.33K |
|
|
CBIO
1400
Crescent Biopharma
CBIO
$602M
| $172K | ﹤0.01% |
182
-35
| -16% | -$42.1K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.